✦ LIBER ✦

Second and third responses to the same induction regimen in relapsing patients with multiple myeloma

✍ Scribed by Adriano Paccagnella; Vanna Chiarion-Sileni; Marcel Soesan; Giovannella Baggio; Sandro Bolzonella; Pietro De Besi; Dario Casara; Michela Frizzarin; Luigi Salvagno; Adolfo Favaretto; Mario V. Fiorentino

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 576 KB
Volume: 68
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19910901)68:5<975::aid-cncr2820680511>3.0.co;2-o

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The efficacy and safety of bortezomib an

The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens

✍ Giulia Benevolo; Alessandra Larocca; Massimo Gentile; Patrizia Pregno; Francesca 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

Treatment of Bendamustine and Prednisone

Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone—a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)

✍ W. Pönisch; P. S. Mitrou; K. Merkle; M. Herold; M. Assmann; G. Wilhelm; K. Dachs 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 344 KB